New York, NY—A study has found citicoline (as Cognizin by Kyowa Hakko USA, based here) improves cognitive function.

Citicoline was administered to 60 women between the ages of 40 and 60 as part of a double blind, placebo-controlled study. The group was broken down into those who received 250 mg of citicoline, those who received 500 mg of citicoline and the placebo group. Both the 250-mg and 500-mg groups made significantly fewer errors on the tests compared with the placebo group. Citicoline has been previously administered to patients with a wide spectrum of cognitive conditions. What made this study interesting was the subject of this study.

“Prior research has shown that citicoline administration improved attention in a variety of patient populations, including those with cognitive deficits associated with illness or injury, but this study included only healthy, middle-aged women,” said the scientists from the University of Utah who administered the study. “To our knowledge, this study is the first to examine the effects of low doses of citicoline on cognitive performance in healthy female adults.”

The study provides optimism for those looking to increase their cognitive functions, specifically attention inhibition.

Published in WholeFoods Magazine, September 2012